Labeler · US market

Prinston Pharmaceutical Inc.

Prinston Pharmaceutical Inc. is a US drug labeler with US FDA registrations covering 1 drug concept (1 currently active) across 4 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes76494

Active drugs1

Registrations4 active / 4

Packages4

Sole supplier of0 drugs

Portfolio1 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Levetiracetam tablet, film coated	rx	4	4	SUPPLYING

At a glance

TypeLabeler
Labeler codes76494
Filing names1
Drugs (active)1
Drugs (all time)1
US registrations4
Packages4

Recent events

Shortages, recalls, and registration changes across all filing names.

Mar 10, 2023
SHORTAGEDrug shortage: Clonazepam Tablet (Prinston Pharmaceutical, Inc.)
Jan 18, 2019
RECALLRecall (Class II): Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co.…
Jan 18, 2019
RECALLRecall (Class II): Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co.…
Jan 18, 2019
RECALLRecall (Class II): Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg Rx Only 90 count Manufactured by: Zhejiang Huahai Pharma…
Jan 18, 2019
RECALLRecall (Class II): Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Only Manufactured by: Zhejiang Huahai Pharmac…
Jan 18, 2019
RECALLRecall (Class II): Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zh…
Jul 13, 2018
RECALLRecall (Class II): Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 80 MG/12.5 MG Tablets, 90-count bottles, Rx Only, Manufactu…
Jul 13, 2018
RECALLRecall (Class II): Solco Healthcare US Valsartan and Hydrochlorothiazide, USP, 160 MG/25 MG Tablets, 90-count bottle, Rx Only, Manufacture…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.